- Home
- / Tibet Duo Rui Pharmaceutical
Tibet Duo Rui Pharmaceutical
Stock Price
¥20.7
2024-10-29
Market Capitalization
¥1.6 B
2024-10-29
Revenue
¥148.2 M
FY, 2025
Tibet Duo Rui Pharmaceutical Summary
Company Summary
- Overview
- Tibet Duo Rui Pharmaceutical ( 西藏多瑞医药股份有限公司) is a manufacturer and distributor of chemical-pharmaceutical preparations and its raw materials. It offers fluid therapy, anesthesiology, analgesic, and first-aid medication, and other products.
- Type
- Public
- Status
- Active
- Founded
- 2016
- Website
- http://www.duoruiyy.com
- Cybersecurity rating
Table of Contents
Tibet Duo Rui Pharmaceutical Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥31.6M
- Gross profit (Q1, 2026)
- ¥1.6M
- Net income (Q1, 2026)
- (¥19.0M)
- Cash (Q1, 2026)
- ¥65.4M
- EBIT (Q1, 2026)
- (¥15.3M)
- Enterprise value
- $1.8B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026